Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of hematologic malignancies; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of hematologic malignancies

'car':20,41 'cell':22,43 'develop':36 'diseas':13 'disord':15 'edit':2,31 'field':18,39 'gene':1,30 'genet':12 'hematolog':28,49 'malign':29,50 'medic':4 'name':3,32 'pharmaceut':33 'research':7,34 'scientif':6 'therapi':23,44 'treatment':10,26,47

Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of hematologic malignancies; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy

'agent':24 'biopharmaceut':23 'cancer':29,53 'car':11,34,58 'cell':1,13,36,60 'clinic':5 'deliveri':47 'field':9,32,56 'gene':38,42 'hematolog':19 'malign':20 'medic':3 'modul':45 'name':41 'pharmaceut':21,48 'product':40 'regul':44 'therapi':14,37,39,61 'transfer':43 'treatment':17,27,51 'use':6

CTX130

Owners

Goods & Services